Evidence map›Paper›PMID 32224139›Full record

ReviewBiochemical pharmacology2020

The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.

Kearsley M Dillon, Ryan J Carrazzone, John B Matson, Khosrow Kashfi

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. NO- and HNitric oxide : biology and chemistry · 2024
    Review
  4. Gas Delivery Relevant to Human Health using Porous Materials.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Utility of NO and HNitric oxide : biology and chemistry · 2022
    Review
  11. Review
  12. Article
  13. Amino acid-based HChemical communications (Cambridge, England) · 2021
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kearsley M DillonDepartment of Chemistry and Macromolecules Innovation Institute, Virginia Tech, Blacksburg, VA 24061, USA; Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, VA 24061, USA.
Ryan J CarrazzoneDepartment of Chemistry and Macromolecules Innovation Institute, Virginia Tech, Blacksburg, VA 24061, USA; Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, VA 24061, USA.
John B MatsonDepartment of Chemistry and Macromolecules Innovation Institute, Virginia Tech, Blacksburg, VA 24061, USA; Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, VA 24061, USA. Electronic address: jbmatson@vt.edu.
Khosrow KashfiDepartment of Molecular, Cellular, and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, 160 Convent Avenue, New York, NY 10031, USA; Graduate Program in Biology, City University of New York Graduate Center, NY, USA. Electronic address: kashfi@med.cuny.edu.
Virginia Tech · USThe Graduate Center, CUNY · US

Funding

Delivery of H2S: Supramolecular and Enzyme-Triggered Strategies for Controlled ReleaseR01GM123508 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI MATSON, JOHN B · 2017 to 2021
$1.6M
NIGMS NIH HHS R01 GM123508
6 · The paper itself

Abstract

Nitric oxide (NO) and hydrogen sulfide (H

Indexed as

Signal TransductionAnimalsCystathionine beta-SynthaseCystathionine gamma-LyaseCysteineGasotransmittersHumansHydrogen SulfideNitric OxideNitric Oxide SynthaseCystathionine beta-SynthaseCystathionine gamma-LyaseCysteineGasotransmittersHydrogen SulfideNitric OxideNitric Oxide SynthaseDelivery platformsFibersH(2)S-releasing hybridsHydrogelsHydrogen sulfideNanoparticlesNitric oxideNO-releasing compoundsPolymers

Identifiers

PMID32224139
PMCPMC7263970
OpenAlexW3013669749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.